Spots Global Cancer Trial Database for cytoreduction
Every month we try and update this database with for cytoreduction cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study | NCT03150628 | Gastric Cancer Peritoneal Carc... HIPEC | Perioperative c... Cytoreduction HIPEC | 18 Years - | UMC Utrecht | |
| Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C | NCT02040142 | Peritoneal Carc... Colorectal Canc... Appendiceal Can... Peritoneal Meso... Pseudomyxoma Pe... Gastric Cancer | HIPEC Mitomycin C | 18 Years - | Albert Einstein College of Medicine | |
| Impact of an Optimised Monitored Anesthesia on the Patients' Recovery After Cytoreduction Surgery Plus HIPEC | NCT04104334 | Hyperthermia Colorectal Neop... Oxaliplatin | Remifentanil in... Remifentanil in... | 18 Years - | Ciusss de L'Est de l'Île de Montréal | |
| Cukurova Score Validation Study | NCT06378905 | Epithelial Ovar... Primary Cytored... | 18 Years - 100 Years | Cukurova University | ||
| Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study | NCT00968799 | Epithelial Ovar... Fallopian Tube ... | Hyperthermic in... Cytoreduction Cisplatin | 18 Years - 70 Years | Cantonal Hospital of St. Gallen | |
| Thiotepa, Busulfan and Fludarabin for pt With Refractory/Early Relapsed Aggressive B-cell Non Hodgkin Lymphomas | NCT01786018 | B-cell Lymphoma... | Thiotepa Busulfan Fludarabin transplant (HCT... Cytoreduction Immunosuppressi... Cyclosporine Methotrexate ATG Collection and ... | 18 Years - 65 Years | Azienda Ospedaliera San Giovanni Battista | |
| Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy | NCT00866554 | Prostate Cancer Erectile Dysfun... Lower Urinary T... | administration ... administration ... | 18 Years - | CHU de Quebec-Universite Laval | |
| Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C | NCT02040142 | Peritoneal Carc... Colorectal Canc... Appendiceal Can... Peritoneal Meso... Pseudomyxoma Pe... Gastric Cancer | HIPEC Mitomycin C | 18 Years - | Albert Einstein College of Medicine | |
| Patient Outcomes Following Interval and Delayed Cytoreductive Surgery in Advanced Ovarian Cancer | NCT05523804 | Ovarian Cancer | interval cytore... delayed cytored... no surgery | 18 Years - | NHS Grampian | |
| Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study | NCT03150628 | Gastric Cancer Peritoneal Carc... HIPEC | Perioperative c... Cytoreduction HIPEC | 18 Years - | UMC Utrecht | |
| Patient Outcomes Following Interval and Delayed Cytoreductive Surgery in Advanced Ovarian Cancer | NCT05523804 | Ovarian Cancer | interval cytore... delayed cytored... no surgery | 18 Years - | NHS Grampian | |
| Patient Outcomes Following Interval and Delayed Cytoreductive Surgery in Advanced Ovarian Cancer | NCT05523804 | Ovarian Cancer | interval cytore... delayed cytored... no surgery | 18 Years - | NHS Grampian | |
| Patient Outcomes Following Interval and Delayed Cytoreductive Surgery in Advanced Ovarian Cancer | NCT05523804 | Ovarian Cancer | interval cytore... delayed cytored... no surgery | 18 Years - | NHS Grampian |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
